About

Listed on the TSX Venture Exchange (TSXV: RX), BioSyent is a profitable growth oriented specialty pharmaceutical company focused on in-licensing or acquiring innovative pharmaceutical products that have been successfully developed, are proven safe and effective, and have track records of improving the lives of patients. BioSyent supports the healthcare professionals that treat these patients by marketing its products through its community, hospital, and international business units. BioSyent continues to search for products to in-license or acquire that are unique and occupy a niche in the market; provide novel technological or therapeutic advantages to patients and healthcare professionals; are backed by strong partners who hold defendable intellectual property rights. BioSyent has been named one of Canada’s fastest growing companies by PROFIT Magazine in 2013, 2014, and 2015.

Channel Info

Performance